The Global Burden of Disease Epidemiology—When Big Data Impute the Nonexistent
Authors:
- 1 April 2024
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 178 (4) , 331-332
Abstract
This Viewpoint discusses concerns about the data quality of the Global Burden of Disease study with respect to incidence estimates of child and adolescent mental health disorders, such as autism and attention-deficit/hyperactivity disorder, in low- and middle-income countries.Keywords
This publication has 9 references indexed in Scilit:
- Optimising adolescent wellbeing in a digital ageBMJ, 2023
- Global prevalence of autism: A systematic review updateAutism Research, 2022
- Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018Morbidity and Mortality Weekly Report, 2021
- Epidemiological Health Information2021
- Association of Race/Ethnicity and Social Disadvantage With Autism Prevalence in 7 Million School Children in EnglandJAMA Pediatrics, 2021
- Epidemiological surveys of ASD: advances and remaining challengesJournal of Autism and Developmental Disorders, 2021
- Social Determinants of Mental Health: Where We Are and Where We Need to GoCurrent Psychiatry Reports, 2018
- Prevalence and socioeconomic correlates of autism among children attending primary and secondary schools in south east NigeriaAfrican Health Sciences, 2017
- Systematic review of general burden of disease studies using disability-adjusted life yearsPopulation Health Metrics, 2012